Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The Prospective P2C2 HIV Multicenter Study - 21/08/11
for the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group
This work was supported by the National Heart, Lung, and Blood Institute, Bethesda, Md (N01-HR-96037, NO1-HR-96038, NO1-HR-96039, NO1-HR-96040, NO1-HR-96041, NO1-HR-96042, NO1-HR-96043), and in part by the National Institutes of Health General Clinical Research Center (Bethesda, Md) grants (RR-00188, RR-00533, RR-00071, RR-00645, RR-00865, and RR-00043).
Résumé |
Background |
Many HIV-infected children die with cardiac abnormalities. We sought to understand the course of these HIV-associated abnormalities and their impact on all-cause mortality.
Methods |
We describe longitudinal changes in left ventricular (LV) structure and function and mortality in 185 children vertically infected with HIV. Serial cardiac data were obtained from 0.1 to 10 years of age. Age- or body surface area–adjusted z scores were calculated for 10 echocardiographic outcomes.
Results |
Median age at first echocardiogram was 2 years (range 0.2-9.4 years); median follow-up was 3.6 years (range 0-6.3 years). The 5-year cumulative incidence of congestive heart failure was 12.3%. Mean fractional shortening z scores declined from −0.65 at 1 year of age to −1.47 at 3 years of age without further decline between 3 and 10 years of age. Among children with 2 echocardiograms performed in the first year of follow-up, mild LV dysfunction (fractional shortening of <−2 SD on both echocardiograms) was present in 29 (18%) of 158 children. For these 29 children, the 5-year mortality was 55.4%. Left ventricular mass z scores were elevated at 1 year (mean z score 0.68, P < .001) and remained elevated throughout follow-up. In the 8 children with LV mass z score of >2 SD on both initial and follow-up echocardiograms, the 5-year mortality was 75%.
Conclusion |
In HIV-infected children, LV structure and function progressively deteriorated in the first 3 years of life, resulting in subsequent persistent mild LV dysfunction and increased LV mass. Chronic mild depression of LV function and elevated LV mass were associated with higher all-cause mortality.
Le texte complet de cet article est disponible en PDF.Plan
Vol 150 - N° 3
P. 439-447 - septembre 2005 Retour au numéro
Article précédent
- Long-term hormone replacement therapy does not cause increased platelet activation
- Marlene S. Williams, Dhananjay Vaidya, Thomas Kickler, Pamela Ouyang
- Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000
- David W. Brown, Gail A. Haldeman, Janet B. Croft, Wayne H. Giles, George A. Mensah
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?